InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Patent Reform Forum USA 2015 - Silicon Valley Speakers

Agenda - Silicon Valley

Agenda - New York

Agenda - New York

Agenda - New York


Contact us

This year's speakers include:

Tom Anderton

General Counsel, Secretary
Zonare Medical Systems

Tom Anderton is currently General Counsel, Secretary at Zonare Medical Systems.

He was previously Vice President, Intellectual Property & Legal Affairs at Presido Pharmaceuticals where he oversaw the legal function at Presidio. Before Presidio, he was the Associate General Counsel and Chief Patent Counsel at Monogram Biosciences, Inc., where he built Monogram's IP portfolio which then was consistently recognized as one of the best IP portfolios in the US. Before going to Monogram, Tom was the Lead Attorney, Oncology at Genencor, Inc. where he developed and implemented Genencor's oncology IP portfolio and led the due diligence team in their in-licensing of BL22, a lymphoma compound developed in Ira Pastan's lab at the NCI. Prior to that, Tom was responsible for envisioning, creating, developing and implementing the patent strategy and portfolio related to the 'virtual' kinase, phosphatase and protease genes that SUGEN cloned from J. Craig Ventner's early human genome sequencing efforts. He was also involved in developing the portfolio that relates to the current Pfizer compound SU11248 (SUTENT).

In private practice, Tom drafted and prosecuted some of the early VEGF-related patents. Before working in the biotech arena, Tom was focused on appellate, constitutional and First Amendment law and was responsible for co-writing trial briefs in the ISKCON v. City of Los Angeles (Hare Krishna/LAX) First Amendment case(s). Tom earned a J.D. from the Vermont Law School, a B.S. in molecular biology from UCSD and an M.S. in Cancer Biology from Stanford University. He has been consistently recognized by his peers as one of the most influential IP practitioners in the United States. He is a member of the State Bar of California and is registered to practice before the United States Patent and Trademark Office.

Anna Johns

Vice President of Licensing

Anna Johns is Vice President of Licensing at Inventergy, Inc., an IP investing and licensing company based in Campbell, California. With 16 years of experience in patent licensing, litigation, acquisition and divestment, Ms. Johns' role focuses on partnering with market-significant technology leaders to help them achieve more value from their world-changing innovations through licensing and divestment, as well as assisting companies of all sizes with their acquisition of patents for defensive purposes. As the former Director of Patent Licensing and Commercialization at Ericsson, she was responsible for all North American revenue-generating patent licensing and divestment activities, with a focus on licensing Ericsson's substantial portfolio of standard-essential patents for mobile communications. Prior to Ericsson, Ms. Johns served as Senior Manager of Patent Licensing at Nokia, where she successfully managed and negotiated the settlement of patent lawsuits and assertions, as well as founded Nokia's WLAN patent licensing program. Ms. Johns began her career in IP as a patent litigation attorney where she focused on the calculation of reasonable royalty and lost profit damages resulting from patent infringement in complex patent lawsuits.

Catherine Lacavera

Director of IP and Litigation

Catherine Lacavera joined Google in 2005. As Director of IP and Litigation, she manages a team of over twenty-five intellectual property attorneys and technical advisors.  She oversees a global litigation docket that has included more than 500 patent and other intellectual property matters, including the Viacom and other copyright litigation against YouTube, and the Apple, Microsoft and Oracle copyright and patent litigation directed at Android.  Ms. Lacavera also advises on complex licenses and acquisitions, including the acquisition of Motorola Mobility for $12.5 billion, the acquisition of Nest for $3.2 billion and the sale of Motorola Home to Arris for $2.2 billion.  She has been named one of Fortune Magazine's 40 Under 40, a U.S. Rising Star by Legal500, one of the most innovative in-house counsel by the Daily Journal, a Rising Star in the Best Bay Area Corporate Counsel Awards, and among the top 40 under 40 by the Silicon Valley Business Journal for significant contributions to the community.  Prior to joining Google, Ms. Lacavera practiced IP litigation in New York City at a large global law firm.

Andrew Filler

General Counsel and Director of Licensing 
3LP Advisors

Andrew Filler currently is General Counsel and Director of Licensing at 3LP Advisors which advises clients on strategy and M&A for technology and intellectual property and is based in San Mateo, CA and Boston, MA.  

Mr. Filler has more than 20 years' experience managing intellectual property and legal matters across an array of technology and medical companies, including creating the industry's dominant patent portfolio for two scientific fields: microfluidics lab-on-a-chip technology, and nanotechnology.  Currently he also serves as an IP advisor at nanotechnology leader Nanosys, as a board advisor to which is an innovative technological service company that is designed to help blind and low-vision users gain independence — serving in essence as a visual interpreter and navigator for users, and as a legal and business advisor to several other technology rich companies in the Silicon Valley.

Prior to his current posts, Filler served as General Counsel and Vice President of IP at Nanosys where he created and managed a portfolio of nanotechnology patents made up of more than 800 patents and applications. In this position, he also negotiated hundreds of licensing and collaborative agreements with companies including Samsung, LG, Intel, Medtronic, 3M, Sharp and SanDisk.

Before joining Nanosys, he served as chief patent counsel at Caliper Life Sciences, where he developed an equally important patent portfolio comprising over 1,000 patents for lab-on-a-chip technology - a field which allows medical and other procedures that normally require a laboratory (such as the analysis of body fluids and the synthesis of chemicals) to be conducted on a very miniaturized scale.

Sabine Agé

Véron & Associés 

Admitted to the Paris Bar in 1994, Sabine Agé has been dedicating herself exclusively to patent litigation since she became a partner of Véron & Associés at the creation of the firm in 2001.

Sabine handles standard related cases in the multimedia systems and telecommunications fields and has acted in particular on behalf of an international telecommunications manufacturer for the French part of worldwide cross-border patent litigations. She is also active in cases relating to pharmaceuticals, chemicals and medical instruments as well as household appliances and consumer goods, for international and domestic industry-based clients as well as research organisations. She deals with legal issues extending from contractual disputes, patent ownership (and co-ownership) to validity and infringement.

Sabine lectures on patent litigation at the International Centre of Intellec-tual Property Studies (CEIPI) in Strasbourg and at the university of Montpellier, in addition to her speaking engagements for conferences.
Sabine Agé is an active member of the International Association for the Protection of Intellectual Property (AIPPI) and secretary to the European Patent Lawyers Association (EPLAW). She is also a member of IPO and AIPLA through Véron & Associés. 

She is co-author of Saisie-contrefaçon, published by the leading French publisher Dalloz and edited by Pierre Véron (third edition, 2012).

Michael Schneider

Wragge, Lawrence, Graham & Co

Michael is a German qualified attorney at law ("Rechtsanwalt") based in Munich, one of the future seats of the UPC. He specialises in contentious and non-contentious IP matters, patent litigation and licensing in particular.  He has experience across all forms of IPR but particularly patent litigation in the high technology and life sciences areas before all relevant German trial and appeal courts. Michael has recently been involved in co-ordinating strategy for a German based exploitation of a wide-ranging European patent portfolio in the telecoms sector involving consideration of seven other European jurisdictions. Michael received his PhD at the Max-Planck-Institute for Intellectual Property Law in Munich and worked at the European Patent Office on European patent litigation projects before joining private practice.  Earlier in his career Michael spent some time working in the US, including an internship at the Court of Appeal for the Federal Circuit.

Bradley Perkins

SVP, General Counsel & Company Secretary
Fingi Inc

With degrees in both law and engineering, and licensed to practice law in California, Hawaii and before the United States Patent and Trademark Office, Brad Perkins has extensive experience in all aspects of corporate work, both doing it himself at smaller startup companies, and supervising others in departments reporting to him at publicly-traded companies. Brad has managed attorneys, engineers, and other professions in legal, engineering, human resources, marketing, public relations, environmental, health and safety, security, and MIS departments.

Brad has been the Vice President and General Counsel of a number of Silicon Valley companies, including Valence Technology, Mission West Properties, Alliance Semiconductor, and Hyperion Solutions Corporation. Most recently, Mr. Perkins was the Senior Vice President, Administration and General Counsel for Tissue Genesis, Inc., a biotech company. He was also a member of the legal departments of Xerox Corporation, Hewlett-Packard company, Ampex Corporation and VLSI Technology, and was counsel to Goodsill Anderson Quinn & Stifel. Currently, he is the Senior Vice President, Engineering, Chief Technical Officer and General Counsel for Fingi Inc., a hospitality technology company.

Amandine Métier

Véron & Associés

Amandine Métier joined Véron & Associés in 2006 as soon as she was admitted to the Paris Bar. She had specialized in intellectual property even before law school, through the Industrial Property Law Master 2 of the University Pantheon-Assas Paris II. She became a partner with Véron & Associés in 2013.

By joining Véron & Associés, Amandine Métier adopted the firm’s motto “100 % patent litigation”: she assists French and foreign companies in the prevention and resolution of disputes involving patents. This approach combines litigation, strategic advice, negotiation, arbitration and mediation.

Like all the 12 lawyers of the firm, Amandine Métier works in all technical fields. However, she is very active in the pharmaceutical field, in chemistry and mechanics. She has also gained special expertise in the field of telecoms through some of the highest profile cases disputed in France involving FRAND issues.

Amandine Métier is also involved in the works of AIPPI (International Association for the Protection of Intellectual Property) and of EPLAW (European Patent Lawyers Association); she is also a member of APEB (Association of the European patent practitioners).

She lectures about patent litigation in the Intellectual Property Master 2 at the University of Lyon III as well as in various conferences and seminars.

David Por

Allen & Overy

David is an experienced litigator specialised in all areas of intellectual property. His practice concentrates primarily on complex and cross-border intellectual property disputes, with a particular focus on patent cases, in which he also advises on validity and freedom to operate issues. David has notably represented leading actors in the patent wars of the telecommunications sector, as well as numerous pharmaceutical companies in proceedings against generics.

David has become a specialist of the interplay between intellectual property and competition law, notably in the field of standardised technologies.

Christopher Parry

Associate General Counsel

Joachim Feldges

Allen & Overy

Joachim has practised complex patent litigation for more than 27 years and across all technical fields, with a particular focus on pharmaceuticals and biotechnology. He has experience developing and implementing international patent litigation strategies in numerous European jurisdictions, including on the requirements arising from parallel patent litigation in the U.S. He represents clients in infringement and validity cases before all major patent courts and he has acted in arbitration proceedings on patent disputes as well as a mediator to settle such disputes.

Joachim regularly represents clients in opposition proceedings before the European Patent Office. In addition, he is involved in the preparatory work for setting up a Unified Patent Court in Europe.

Greg Warder

Director, IP Legal
Maxim Integrated

Greg Warder has spent the last decade working in-house overseeing patent programs for public technology companies.  He also has extensive law-firm experience representing major corporate clients in complex patent matters.  In his current position as IP Director with Maxim Integrated Products, he is responsible for a broad range of legal issues including patent portfolio management/monetization, litigation, technology licensing, and M&A transactions.  Mr. Warder previously served as a patent examiner with the U.S. Patent and Trademark Office, and has worked as an engineer in the telecommunications and electronics industries.

Tim Hargreaves

Marks & Clerk

Tim is a Chartered and European Patent Attorney and works in the fields of electronics, physics, engineering and computer-related inventions.

He works with ranging clients, from large multinationals to SMEs, Universities and start-ups, and his extensive experience covers many areas of patent practice, including large scale, cross-border due diligence and product clearance projects. Tim also represents clients in both examination and opposition hearings before the European Patent Office.

Tim works on a wide range of technologies, with particular experience in computer-related inventions, medical devices, medical imaging, signal processing, photonics, solid state physics, semiconductors, networking and communication technologies, aircraft systems, oil and gas-related technologies, and financial systems including ATMs and payment card systems.

Previously, Tim was based and worked in the London and Paris offices of Marks & Clerk. He graduated from Nottingham University with a first class honours degree in physics before obtaining a doctorate from Sussex University for research in low temperature physics. Thereafter, Tim undertook post-doctoral research at the Commissariat à l'Énergie Atomique in Grenoble, France studying strongly correlated electronic systems, including heavy fermions and high temperature superconductors.

William Cook

Marks & Clerk

William is an intellectual property lawyer and partner at Marks & Clerk Solicitors. He specialises in and is best known for his work litigating patents for clients in the TMT sector. He advises major corporations and technology companies, in particular relating to patents covering electronics, semiconductors, telecoms technology, software and related fields. He heads up Marks & Clerk Solicitors’ TMT practice.

He has a wealth of experience conducting patent litigation in the specialist UK IP courts and at the Court of Appeal.  William also regularly advises clients in multi-jurisdictional disputes with parallel proceedings in other European jurisdictions and/or the USA. He is currently advising Virgin Media in the long-running Rovi v Virgin Media and TiVo litigation, among other high profile patent matters.

William is listed or ranked in leading legal directories including Legal 500, Chambers & Partners, IAM Patent 1000, Managing Intellectual Property IP Stars and Who’s Who Legal.

Marianne Schaffner


Marianne Schaffner is the National head of the Intellectual Property Group of Dechert in Paris as well as the National co-head of the Life Sciences Group of Dechert Paris. Marianne has extensive experience in strategic domestic, pan-European and international patent and trade secrets disputes for a diverse array of companies, in particular in the Life Sciences, Electronics and Telecoms sectors. As lead counsel, she often coordinates cross-border patent disputes in Europe and in the United States. She has a very good knowledge of the US litigation system (discovery and estoppels notably) and such expertise is a pre-requisite for each client litigating in Europe and in the US. She is also very familiar with the UK and German litigation systems, as she worked in the UK and Germany as well as with the Belgian system as she appears, as co-counsel, before the Belgian Courts. Marianne also advises clients on intellectual property agreements, patent portfolio, patent validity and freedom to operate issues.

Marianne is co-chair of the Life Sciences Patents Committee of the International Association for the Protection of Intellectual Property (AIPPI), board member of the French Trademark and Design Association (APRAM), member of the Public Resources Committee of the International Trademark Association (INTA) and member of the Licensing Executive Society (LES). She is also a lecturer in the Advanced Post Master, Research and Valorisation of IP program at the University of Poitiers. She is fluent in French, English and German and understands Dutch.

Rosie Hardy

UK and European Patent Attorney
Withers & Rogers

Rosie's practice spans the fields of physics, engineering and electronics. Within these fields she has extensive experience in securing patent protection for electromechanical devices, power generation, clean technology, automotive parts, rail, oil and gas exploration, medical apparatus and consumer products.

Rosie works with a wide range of clients from individuals to multinational corporations, universities, overseas clients and business support agencies. Working closely with her clients, she has particular expertise in developing commercially effective intellectual property portfolios. In addition to drafting and prosecuting patent applications, Rosie specialises in managing and enforcing patent rights for her clients as well as opposing and avoiding infringement of third party patents.

Recent highlights include successfully opposing certain key European patents belonging to a competitor and speaking at a series of conferences in the USA on changes to the European Patent System.

Jürgen Neugebauer


Jürgen Neugebauer, a partner with CASALONGA in Munich since 2008, has practiced Patent Law since 1993. Heis a German Patent Attorney and is also admitted as European Patent Attorney before the European Patent Office (EPO) in Munich. He has extensive experience in opposition and oral procedures before the EPO. He frequently speaks at various patent conferences including the JPAA (Japan Patent Attorneys Association) study groups on European Patent Law in Tokyo. The CASALONGA Munich office, part of the CASALONGA IP group with more than 100 professionals and offices in Munich, Paris, Grenoble, Toulouse and Alicante, focuses on European patents and on the future EP litigation before the Munich local division and the mechanical cluster of Central Division of the European Patent Court (EPC).

Caroline Casalonga


Caroline Casalonga, managing partner of CASALONGA and based in the Paris office, is a French lawyer, specialized in IP litigation with extensive experience in litigation before the French IP courts. She represents technology companies in patent litigation as well as IP litigation in general. . The Paris office of the CASALONGA group, a European IP firm, with more than 100 professionals and offices in Munich, Paris, Grenoble, Toulouse and Alicante, focuses on French and European IP litigation and prosecution and on the future EP litigation before the Paris Central Division of the European Patent Court (EPC) and the Paris local division.Ms. Casalonga has been a member of the Paris bar since 1995. She received her LLM from Cornell University (1996) and subsequently worked with Pennie & Edmonds in NYC. This experience has enabled her to better understand the needs of US and other international clients. Ms. Casalonga is an active member of the EPLAW (European patent lawyer association), INTA, AIPPI, LES, ECTA, CAPIP (Coalition Against Piracy Intellectual Property).

Nigel Stoate

Taylor Wessing


Shawn Ambwani

Unified Patents

Mike Willardson

IP Attorney/Tech Transfer Chief 
Stanford University - SLAC National Accelerator Laboratory

Mike is currently the Technology Transfer Chief for SLAC National Accelerator Laboratory, which is a Department of Energy funded research lab operated by Stanford University. At SLAC, Mike focuses on establishing industry partnerships with domestic and international technology companies to advance research and development activities in multiple technology areas. SLAC is part of an international community of particle physics and fundamental research labs, and develops significant IP which Mike manages in collaboration with Stanford’s Office of Technology Licensing.

Prior to his position at SLAC, Mike was in-house counsel for many private sector IP-focused technology companies including Intel Corporation, Canon, and most recently, NuScale Power. Mike was the Director of IP for NuScale Power, and while at NuScale he architected and executed on an IP portfolio development strategy which resulted in NuScale filing and obtaining title to hundreds of U.S. and International patents and patent applications in over 20 countries. As an engineer turned lawyer, Mike has experienced the importance of international collaborations to advance technology, as well as the need to have a global IP strategy tailored to a company’s short and long term business strategy.




Freshfields Bruckhaus Deringer 



Withers & Rogers

Wragge Lawrence Graham & Co

Vernon & Associes


Supporting Organisations

More from the Managing IP blog


null null null

null null null

Mid Year 2018

PTAB practice in a post-SAS world

The big questions remaining after the Supreme Court’s SAS ruling include how institution rates will change, how strategy at the Board should evolve, and how district courts and the Federal Circuit will react. Michael Loney investigates

Most read articles